Breath-Triggered Drug Release System for Preterm Neonates

A major disadvantage of inhalation therapy with continuous drug delivery is the loss of medication during expiration. Developing a breath-triggered drug release system can highly decrease this loss. However, there is currently no breath-triggered drug release directly inside the patient interface (n...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiegandt, Felix C., Froriep, Ulrich P., Müller, Fabian, Doll, Theodor, Dietzel, Andreas, Pohlmann, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147847/
https://www.ncbi.nlm.nih.gov/pubmed/34064425
http://dx.doi.org/10.3390/pharmaceutics13050657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147847/
https://www.ncbi.nlm.nih.gov/pubmed/34064425
http://dx.doi.org/10.3390/pharmaceutics13050657

Ejemplares similares